Circadian Variations in Theophylline Concentrations and the Treatment of Nocturnal AsthmaMartin, Richard J.; Cicutto, Lisa C.; Ballard, Robert D.; Goldenheim, Paul D.; Cherniack, Reuben M. · American Review of Respiratory Disease · 1989

Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.Weersink, E J; Douma, R R; Postma, D S; Koëter, G H · American Journal of Respiratory and Critical Care Medicine · 1997

Treatment of Nocturnal Asthma: the Role of Sustained-Release Theophylline and Oral β-2-MimeticsWilkens, Jan H.; Wilkens, Heinrike; Heins, Michael; Kurtin, Lidija; Oellerich, Michael; Sybrecht, Gerhard W. · Chronobiology International · 1987

Nocturnal asthma: Effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combinationDahl, Ronald; Pedersen, Bente; Hägglöf, Björn · Journal of Allergy and Clinical Immunology · 1989

Circadian Rhythms in the Pharmacokinetics and Clinical Effects of Beta-agonist, Theophylline, and Anticholinergic Medications in the Treatment of Nocturnal AsthmaD'alonzo, Gilbert E.; Crocetti, Joseph G.; Smolensky, Michael H. · Chronobiology International · 1999

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthmaMartin, Richard J.; Kraft, Monica; Beaucher, Wilfred N.; Kiechel, Frederic; Sublett, James L.; LaVallee, Nicole; Shilstone, Jonathan · 1999

Computer model accurately predicts chemotherapy responseInpharma Weekly · 2006

AzodicarbonamideInpharma Weekly · 1999

Recommendations for treatment of severe aplastic anaemiaInpharma Weekly · 1994

Did you know about R&D costs?Inpharma Weekly · 1993

R&D investment in JapanInpharma Weekly · 1993

NICE creates new R&D committeeInpharma Weekly · 2003

Gallic acid has potential in lung cancerInpharma Weekly · 2002

New mesalazine formulation advantageous in IBDInpharma Weekly · 2001